Observational studyBMC cancer2025

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.

Martin Boegemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.